Structure Therapeutics Inc. (GPCR) has a consensus analyst rating of Buy, based on 14 analysts covering the stock. Of those, 14 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for GPCR is $116.71, representing a +119.4% upside from the current price of $53.194. Price targets range from a low of $90.00 to a high of $145.00.
